Search research articles
Contact Us
Filters
Showing results (51-60 of 94) with videos related to
Page
of 10
Sort By:
Therapie
|
September 1, 1992
[Neurologic side effects of fluoroquinolones. Apropos of 9 cases concerning pefloxacin]
M Andrejak, J L Schmit, A Tondriaux, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
September 16, 2000
[Effect of methyclothiazide on the entry of calcium into vascular smooth muscle cells]
B Colas, J L Colas, H Masson, et al.
Therapie
|
November 1, 1990
Thrombocytopenia with or without thrombosis after pentosan polysulfate treatment
J F Claisse, M Andrejak, G Jarry, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
August 1, 1990
Type 2 diabetes in the elderly: an assessment of metformin (metformin in the elderly)
J D Lalau, A Vermersch, L Hary, et al.
British Journal of Clinical Pharmacology
|
February 12, 1998
Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database
N Moore, C Kreft-Jais, F Haramburu, et al.
Coeur Et Medecine Interne
|
July 1, 1978
[Beta blockaders in the treatment of hypertension. Part 2. Antihypertensive effect: hypotheses on the mechanism of action and practical methods of treatment]
M Andrejak, A Fournier, J M Hardin, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1984
[Acute hepatitis due to carbamazepine (Tegretol). Study of a case and review of the literature]
T Davion, J P Capron, M Andrejak, et al.
Therapie
|
September 1, 1994
[Convulsions associated with the administration of excessive dose of ceftazidime in patients with renal failure]
E Chetaille, K Masmoudi, L Dimier-David, et al.
Nephrologie
|
January 1, 1981
[Diuretics and vascular risk factors. Comparison between tienilic acid and chlorothiazide (author's transl)]
M Andrejak, R Makdassi, J F de Frémont, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1991
Pharmacokinetics of single-dose intravenous, oral, and intraperitoneal pefloxacin in patients on chronic ambulatory peritoneal dialysis
J L Schmit, L Hary, P Bou, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 94) with videos related to
Sort By:
Page
of 10
Therapie
|
September 1, 1992
[Neurologic side effects of fluoroquinolones. Apropos of 9 cases concerning pefloxacin]
M Andrejak, J L Schmit, A Tondriaux, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
September 16, 2000
[Effect of methyclothiazide on the entry of calcium into vascular smooth muscle cells]
B Colas, J L Colas, H Masson, et al.
Therapie
|
November 1, 1990
Thrombocytopenia with or without thrombosis after pentosan polysulfate treatment
J F Claisse, M Andrejak, G Jarry, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
August 1, 1990
Type 2 diabetes in the elderly: an assessment of metformin (metformin in the elderly)
J D Lalau, A Vermersch, L Hary, et al.
British Journal of Clinical Pharmacology
|
February 12, 1998
Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database
N Moore, C Kreft-Jais, F Haramburu, et al.
Coeur Et Medecine Interne
|
July 1, 1978
[Beta blockaders in the treatment of hypertension. Part 2. Antihypertensive effect: hypotheses on the mechanism of action and practical methods of treatment]
M Andrejak, A Fournier, J M Hardin, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1984
[Acute hepatitis due to carbamazepine (Tegretol). Study of a case and review of the literature]
T Davion, J P Capron, M Andrejak, et al.
Therapie
|
September 1, 1994
[Convulsions associated with the administration of excessive dose of ceftazidime in patients with renal failure]
E Chetaille, K Masmoudi, L Dimier-David, et al.
Nephrologie
|
January 1, 1981
[Diuretics and vascular risk factors. Comparison between tienilic acid and chlorothiazide (author's transl)]
M Andrejak, R Makdassi, J F de Frémont, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1991
Pharmacokinetics of single-dose intravenous, oral, and intraperitoneal pefloxacin in patients on chronic ambulatory peritoneal dialysis
J L Schmit, L Hary, P Bou, et al.
Page
of 10